GB1542178A - 5-m-tolyloxy-uracil anti-ulcer agent - Google Patents

5-m-tolyloxy-uracil anti-ulcer agent

Info

Publication number
GB1542178A
GB1542178A GB7729667A GB2966777A GB1542178A GB 1542178 A GB1542178 A GB 1542178A GB 7729667 A GB7729667 A GB 7729667A GB 2966777 A GB2966777 A GB 2966777A GB 1542178 A GB1542178 A GB 1542178A
Authority
GB
United Kingdom
Prior art keywords
tolyloxy
uracil
ulcer agent
ulcer
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7729667A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Publication of GB1542178A publication Critical patent/GB1542178A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
GB7729667A 1976-07-16 1977-07-14 5-m-tolyloxy-uracil anti-ulcer agent Expired GB1542178A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/706,123 US4080454A (en) 1976-07-16 1976-07-16 5-M-Tolyloxyuracil, anti-ulcer agent

Publications (1)

Publication Number Publication Date
GB1542178A true GB1542178A (en) 1979-03-14

Family

ID=24836300

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7729667A Expired GB1542178A (en) 1976-07-16 1977-07-14 5-m-tolyloxy-uracil anti-ulcer agent

Country Status (29)

Country Link
US (1) US4080454A (cg-RX-API-DMAC10.html)
JP (1) JPS5337673A (cg-RX-API-DMAC10.html)
AR (1) AR213652A1 (cg-RX-API-DMAC10.html)
AT (1) AT351561B (cg-RX-API-DMAC10.html)
BE (1) BE856710A (cg-RX-API-DMAC10.html)
CA (1) CA1061788A (cg-RX-API-DMAC10.html)
CH (1) CH622512A5 (cg-RX-API-DMAC10.html)
CS (1) CS212264B2 (cg-RX-API-DMAC10.html)
DD (1) DD131556A5 (cg-RX-API-DMAC10.html)
DE (1) DE2731736A1 (cg-RX-API-DMAC10.html)
DK (1) DK139029B (cg-RX-API-DMAC10.html)
EG (1) EG12762A (cg-RX-API-DMAC10.html)
ES (1) ES460686A1 (cg-RX-API-DMAC10.html)
FI (1) FI772183A7 (cg-RX-API-DMAC10.html)
FR (1) FR2358399A1 (cg-RX-API-DMAC10.html)
GB (1) GB1542178A (cg-RX-API-DMAC10.html)
GR (1) GR68686B (cg-RX-API-DMAC10.html)
HU (1) HU177713B (cg-RX-API-DMAC10.html)
IL (1) IL52409A (cg-RX-API-DMAC10.html)
LU (1) LU77764A1 (cg-RX-API-DMAC10.html)
NL (1) NL7707729A (cg-RX-API-DMAC10.html)
NO (1) NO772489L (cg-RX-API-DMAC10.html)
PH (1) PH13190A (cg-RX-API-DMAC10.html)
PL (1) PL103783B1 (cg-RX-API-DMAC10.html)
PT (1) PT66808B (cg-RX-API-DMAC10.html)
SE (1) SE421125B (cg-RX-API-DMAC10.html)
SU (1) SU673169A3 (cg-RX-API-DMAC10.html)
YU (1) YU171677A (cg-RX-API-DMAC10.html)
ZA (1) ZA773927B (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55158095A (en) * 1979-05-25 1980-12-09 Zenkosha Tokei Kk Controller for washing machine
KR101452518B1 (ko) * 2005-08-22 2014-10-21 멜리어 파마슈티칼스 아이, 인코포레이티드 Lyn 키나제 활성의 조절 및 관련된 장애의 치료를 위한방법 및 제제
EP2120581A4 (en) * 2007-02-20 2011-03-16 Melior Pharmaceuticals I Inc METHODS OF IDENTIFYING LYN KINASE ACTIVATORS
EP2180894A4 (en) * 2007-07-23 2012-08-29 Melior Pharmaceuticals I Inc METHOD OF ACTIVATING IRS-1 AND ACT
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
WO2011150300A1 (en) * 2010-05-28 2011-12-01 Melior Pharmaceuticals I, Inc. Prevention of pancreatic beta cell degeneration
EP3609500B1 (en) 2017-04-10 2024-11-13 Melior Pharmaceuticals I, Inc. Treatment of adipocytes
CA3088178A1 (en) 2018-02-21 2019-08-29 Melior Pharmaceuticals I, Inc. Treatment of liver diseases
WO2026125941A1 (en) 2024-12-13 2026-06-18 Biodexa Ltd. Lyn kinase activators for use in treating fibrosis or diseases associated with fibrosis

Also Published As

Publication number Publication date
PH13190A (en) 1980-01-16
US4080454A (en) 1978-03-21
BE856710A (fr) 1978-01-11
SE7707471L (sv) 1978-01-17
DK318177A (cg-RX-API-DMAC10.html) 1978-01-17
JPS5337673A (en) 1978-04-06
SE421125B (sv) 1981-11-30
SU673169A3 (ru) 1979-07-05
JPS5512017B2 (cg-RX-API-DMAC10.html) 1980-03-29
AR213652A1 (es) 1979-02-28
GR68686B (cg-RX-API-DMAC10.html) 1982-02-01
NL7707729A (nl) 1978-01-18
AT351561B (de) 1979-08-10
DD131556A5 (de) 1978-07-05
PL103783B1 (pl) 1979-07-31
IL52409A (en) 1979-11-30
HU177713B (en) 1981-12-28
FR2358399B1 (cg-RX-API-DMAC10.html) 1980-10-17
NO772489L (no) 1978-01-17
CH622512A5 (cg-RX-API-DMAC10.html) 1981-04-15
CS212264B2 (en) 1982-03-26
YU171677A (en) 1982-06-30
EG12762A (en) 1979-12-31
IL52409A0 (en) 1977-08-31
DK139029C (cg-RX-API-DMAC10.html) 1979-05-07
AU2663877A (en) 1978-05-18
PT66808A (en) 1977-08-01
ES460686A1 (es) 1978-12-01
FI772183A7 (cg-RX-API-DMAC10.html) 1978-01-17
ZA773927B (en) 1978-05-30
PT66808B (en) 1978-12-21
DE2731736A1 (de) 1978-01-26
LU77764A1 (cg-RX-API-DMAC10.html) 1978-02-02
CA1061788A (en) 1979-09-04
PL199633A1 (pl) 1978-04-10
FR2358399A1 (fr) 1978-02-10
DK139029B (da) 1978-12-04
ATA509277A (de) 1979-01-15

Similar Documents

Publication Publication Date Title
JPS52145525A (en) Local antiiinflammation agent
JPS52134027A (en) Antiitumor agent
JPS5325525A (en) Radiooopaque agent
JPS5470433A (en) Antiiulcer agent
JPS5299230A (en) Antiitumor agent
JPS52118497A (en) Antiiallergy agent
JPS5297933A (en) Antiihypertensive agent
PH13190A (en) 5-m-tolyloxyuracil,anti-ulcer agent
JPS535195A (en) Antiibacterial agent
IL52048A0 (en) Immunostimulating agent
JPS52117436A (en) Antiicoccidium agent
JPS5335084A (en) Airzol size agent
JPS53105113A (en) Ijushinkinosukuriinnikoreohyojisurushisutemu
SU725543A3 (en) Insecticidic agent
JPS5386040A (en) Antiicoagulating agent
JPS5324016A (en) Mothproofing agent
JPS5297963A (en) Antiihypertensive agent
JPS52114025A (en) Antiitumor agent
JPS5372828A (en) Antiicancer agent
JPS5377055A (en) Antiilinoovirus agent
JPS5297967A (en) Antiihypertensive agent
JPS5379012A (en) Antiicancer agent
JPS5331693A (en) Antiibacterial agents
PT67012B (en) Antimalignant agent
JPS52130932A (en) Antiisolidifying agent

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee